Jade Biosciences (JBIO) Other Gross PP&E Adjustments (2020 - 2026)
Jade Biosciences (JBIO) reported Other Gross PP&E Adjustments of -$690000.0 for Q1 2026, down 336.71% on a YoY basis from $291497.3 in Q1 2025, and up 58.16% quarter-over-quarter from -$1.6 million in Q4 2025.
Jade Biosciences (JBIO) Other Gross PP&E Adjustments (2020 - 2026) Analysis & Trends
Jade Biosciences has reported Other Gross PP&E Adjustments for 7 years, with the latest figure at -$690000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments fell 336.71% year-over-year to -$690000.0; the trailing twelve-month figure through Mar 2026 stood at -$690000.0 (down 336.71% YoY), and the FY2025 full-year result was -$1.6 million, down 616.96% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$690000.0, up from -$1.6 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was -$158000.0 in Q1 2025, with the low at -$2.5 million in Q4 2023.
- Historically, Other Gross PP&E Adjustments has averaged -$913588.2 across 5 years, with a median of -$740000.0 in 2025.
- Annual changes were most pronounced in 2022 — Other Gross PP&E Adjustments plunged 3070.0% — and 2024, when it jumped 90.96%.
- Jade Biosciences' Other Gross PP&E Adjustments stood at -$1.9 million in 2022, then slumped by 32.04% to -$2.5 million in 2023, then jumped by 90.96% to -$230000.0 in 2024, then tumbled by 616.96% to -$1.6 million in 2025, then soared by 58.16% to -$690000.0 in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$690000.0 (Q1 2026), -$1.6 million (Q4 2025), and -$740000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | -60,691.22 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -83,048.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -285.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -892,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -1.69 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Jade Biosciences | 877.06 Mn | 877.06 Mn | - | -690,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -690,000.00 |
| Mar 31, 2026 | -690,000.00 |
| Dec 31, 2025 | -1.65 Mn |
| Dec 31, 2025 | -1.65 Mn |
| Sep 30, 2025 | -740,000.00 |
| Sep 30, 2025 | -740,000.00 |
| Jun 30, 2025 | -777,000.00 |
| Jun 30, 2025 | -777,000.00 |
| Mar 31, 2025 | -158,000.00 |
| Mar 31, 2025 | -158,000.00 |
| Dec 31, 2024 | -230,000.00 |
| Dec 31, 2024 | -230,000.00 |
| Sep 30, 2024 | -259,000.00 |
| Sep 30, 2024 | -259,000.00 |
| Jun 30, 2024 | -621,000.00 |
| Jun 30, 2024 | -621,000.00 |
| Mar 31, 2024 | -725,000.00 |
| Mar 31, 2024 | -725,000.00 |
| Dec 31, 2023 | -2.54 Mn |
| Dec 31, 2023 | -2.54 Mn |